Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

Granulation and epithelialization are crucial for healing large skin wounds.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

New technologies help better understand and treat inflammatory skin diseases.

Skin heals with scars because only one type of fibroblast is used, not a mix.

Cholecystokinin may help reduce skin inflammation in psoriasis.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Fish oil improves skin health in people with diabetes and high cholesterol.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Different types of dog hair loss are linked to problems starting the hair growth phase and early hair cycle ending.

Herbal anti-dandruff shampoos can be as effective as synthetic ones, with fewer side effects.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Blocking IL-17a can improve age-related smell loss in mice.

Erianin may effectively treat alopecia areata by targeting the immune system.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Skin tumor regression is helped by retinoic acid signaling blocking Wnt signaling.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.

Curcumin spanlastics are the most effective for cancer therapy due to their strong antimicrobial, antioxidant, and antitumor effects.

Polyomavirus A2 infection in newborn mice caused hair follicle tumors.

Ovol2 is crucial for hair growth and skin healing by controlling cell movement and growth.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.